
Generation of high quality leads is a critical stage in the drug discovery process – the better the lead the more likely a high quality candidate compound will be identified rapidly.
We provide hit identification taking advantage of our computational chemistry and extensive experience of rational drug design.
Hits from these strategies or from clients screening campaigns are subsequently validated exploiting our medicinal chemistry expertise and our ADMET developability and PK capabilities resulting in high quality leads for progression to full lead optimization.
For more information please contact: info@nikemresearch.com